Pfizer Healthcare India Private Limited

FDA inspection history across 2 sites, 2019 to 2023

2
Close-outs
2
Form 483s

Every document, by year

  • Close-out
  • Form 483

2019: one Form 483; 2020: one close-out letter; 2022: one Form 483; 2023: one close-out letter.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2019–23Two Form 483s and two close-out letters, at Visakhapatnam, India and New York, New York.
  2. 2022The longest 483 on file: 1 observation over 3 pages at Visakhapatnam, India.

Cited most

Across all Pfizer Healthcare India Private Limited observations on file

The complete Pfizer Healthcare India Private Limited file.

All 4 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$396

The price of the documents, added to your cart together

Sites

Documents

4 on file, newest first
DateDocumentPrice
2023-02-08Close-out Close-out letter$99
2022-10-18483 Form 483$99
2020-03-25Close-out Close-out letter$99
2019-09-06483 Form 483$99

Investigators on these documents

Jose E. Melendez (1)Junho Pak (1)

FEI number 3008316085 · most recent document Feb 8, 2023

About Pfizer Healthcare India Private Limited

How many FDA Form 483s has Pfizer Healthcare India Private Limited received?

FDA Intel has 2 Form 483s on file for Pfizer Healthcare India Private Limited; the most recent is dated Oct 18, 2022.

When was Pfizer Healthcare India Private Limited last inspected by FDA?

The most recent FDA inspection document on file for Pfizer Healthcare India Private Limited is a Form 483 dated Oct 18, 2022, for the site in Visakhapatnam, India.

What did FDA cite at Pfizer Healthcare India Private Limited?

The regulations cited most in the observations on file for Pfizer Healthcare India Private Limited are 21 CFR 211.113 (Control of microbiological contamination), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time.